Literature DB >> 11393486

Trends in screening for colorectal cancer--United States, 1997 and 1999.

.   

Abstract

Colorectal cancer is the second leading cause of cancer-related death in the United States. An estimated 135,400 new cases and 56,700 deaths from colorectal cancer are expected during 2001. Since the mid-1990s, national guidelines have recommended that persons aged >50 years at average risk for colorectal cancer should have screening tests regularly. To estimate rates for the use of colorectal cancer screening tests and to evaluate trends in test use, CDC analyzed data from the 1999 Behavioral Risk Factor Surveillance System (BRFSS) on the use of a home administered fecal occult blood test (FOBT) and sigmoidoscopy/colonoscopy, and then compared them with similar data from 1997. The findings in this report indicate that the proportion of the U.S. population that has been screened remains low. In 1999, 44% of BRFSS respondents reported receiving FOBT and/or sigmoidoscopy/colonoscopy within the recommended period compared with approximately 41% reporting FOBT and/or sigmoidoscopy/proctoscopy within the recommended period in 1997. Efforts to address barriers and to promote the use of colorectal cancer screening should be intensified.

Entities:  

Mesh:

Year:  2001        PMID: 11393486

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  37 in total

1.  A computerized intervention to promote colorectal cancer screening for underserved populations: theoretical background and algorithm development.

Authors:  K Allen Greiner; Mugur V Geana; Aaron Epp; Angela Watson; Melissa Filippi; Christine Makosky Daley; Kimberly K Engelman; Aimee S James; Marci Campbell
Journal:  Technol Health Care       Date:  2012       Impact factor: 1.285

2.  Experience of a public health colorectal cancer testing program in Maryland.

Authors:  Diane M Dwyer; Carmela Groves; Annette Hopkins; Eithne Keelaghan; Fatma M Shebl; Barbara Andrews; Marsha Bienia; Eileen Steinberger
Journal:  Public Health Rep       Date:  2012 May-Jun       Impact factor: 2.792

Review 3.  Two countries divided by a common language: health systems in the UK and USA.

Authors:  Monica Desai; Bernard Rachet; Michel P Coleman; Martin McKee
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

4.  An evidence-based microsimulation model for colorectal cancer: validation and application.

Authors:  Carolyn M Rutter; James E Savarino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

5.  Screening for colon cancer.

Authors:  J P Heiken
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

6.  The impact of physicians' health beliefs on colorectal cancer screening practices.

Authors:  Kenneth Shieh; Feng Gao; Stephen Ristvedt; Mario Schootman; Dayna Early
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

Review 7.  Cervical cancer screening.

Authors:  Dorothy J Wiley; Bradley J Monk; Emmanuel Masongsong; Kristina Morgan
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

8.  Barriers and facilitators of colon cancer screening among patients at faith-based neighborhood health centers.

Authors:  Melissa Tabbarah; Mary Patricia Nowalk; Mahlon Raymund; Ilene K Jewell; Richard K Zimmerman
Journal:  J Community Health       Date:  2005-02

9.  A randomized controlled trial to increase cancer screening among attendees of community health centers.

Authors:  Richard G Roetzheim; Lisa K Christman; Paul B Jacobsen; Alan B Cantor; Jennifer Schroeder; Rania Abdulla; Seft Hunter; Thomas N Chirikos; Jeffrey P Krischer
Journal:  Ann Fam Med       Date:  2004 Jul-Aug       Impact factor: 5.166

10.  Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy.

Authors:  Parvathi A Myer; Ajitha Mannalithara; Gurkirpal Singh; Uri Ladabaum
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.